Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Heart Journal

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/EHI028PMID 15618054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Systemic Inflammatory Response to Cardiac Surgery: Implications for the Anesthesiologist

  2002cited by this paper
• Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia

  2000cited by this paper
• Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia.

  2000cited by this paper
• ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certifi

  1999cited by this paper
• Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery

  1998cited by this paper
• Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation.

  1997cited by this paper
• Role of leucocytes in free radical production during myocardial revascularisation.

  1997cited by this paper
• Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation.

  1996cited by this paper
• Effects of pentastarch-deferoxamine conjugate on lung injury after cardiopulmonary bypass.

  1996cited by this paper
• Role of oxygen-derived free radicals in canine reperfusion arrhythmias.

  1995cited by this paper
• Deferoxamine cardioplegia reduces superoxide radical production in human myocardium.

  1995cited by this paper
• Studies of hypoxemic/reoxygenation injury: without aortic clamping. VII. Counteraction of oxidant damage by exogenous antioxidants: coenzyme Q10.

  1995cited by this paper
• Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion.

  1995cited by this paper
• STUDIES OF HYPOXEMIC/ REOXYGENATION INJURY: WITHOUT AORTIC CLAMPING

  1995cited by this paper
• Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.

  1994cited by this paper
• Coronary Endothelial Injury After Cardiopulmonary Bypass and Ischemic Cardioplegia Is Mediated by Oxygen‐Derived Free Radicals

  1993cited by this paper
• Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.

  1993cited by this paper
• Myocardial Glucose Uptake in Patients With Insulin‐Dependent Diabetes Mellitus Assessed Quantitatively by Dynamic Positron Emission Tomography

  1993cited by this paper
• Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity.

  1992cited by this paper
• The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection.

  1992cited by this paper
• Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease.

  1990cited by this paper
• Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans.

  1990cited by this paper
• Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium.

  1990cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• Amelioration of postischemic stunning by deferoxamine-blood cardioplegia.

  1989cited by this paper
• Importance of early recanalization of the occluded coronary artery in acute myocardial infarction for preservation of left ventricular function.

  1988cited by this paper
• Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man.

  1988cited by this paper
• Free radical effects on membrane protein in myocardial ischemia/reperfusion injury.

  1987cited by this paper
• Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow.

  1987cited by this paper
• Perioperative evaluation of regional wall motion by transesophageal two-dimensional echocardiography.

  1987cited by this paper
• Oxidative stress during myocardial ischaemia and reperfusion: Experimental and clinical evidence

  1986cited by this paper
• Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts.

  1986cited by this paper
• Role of metals in oxygen radical reactions.

  1985cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper
• Desferrioxamine: a scavenger of superoxide radicals?

  1984cited by this paper
• Effect of a specific iron chelating agent on animal models of inflammation.

  1983cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.

  1983cited by this paper
• Possible role for cytotoxic oxygen metabolites in the pathogenesis of cardiac ischemic injury.

  1982cited by this paper
• Biology of disease: free radicals and tissue injury.

  1982cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

  1979cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper

• CD44 alleviates myocardial ischemia reperfusion injury through repressing ferroptosis.

  2026cites this paper
• Lipoperoxidación de membranas y daño ultraestructural por estrés oxidativo en isquemia-reperfusión miocárdica

  2026cites this paper
• Phase-dependent iron dysmetabolism in myocardial ischemia-reperfusion injury: From mechanisms to therapies

  2025cites this paper
• Xrcc6 coordinates cardiomyocyte repair and immune regulation in myocardial ischemia-reperfusion injury: Fisetin as a therapeutic modulator

  2025cites this paper
• Antioxidant Cardioprotection in Acute Myocardial Infarction: From Mechanisms to Therapeutic Strategies.

  2025cites this paper
• New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine

  2025cites this paper
• Potential role of AhR in ischemia-reperfusion injury and cancers: Focus on ferroptosis and lipid peroxidation signaling pathways (Review)

  2025cites this paper
• Supersaturated Oxygen Therapy in Acute Myocardial Infarction: Mechanisms, Efficacy, and Future Direction.

  2025cites this paper
• The peptide from C- Phycocyanin alleviates myocardial ischemia-reperfusion injury by suppressing ferroptosis via upregulating UCHL3.

  2025cites this paper
• Ferroptosis spreads to neighboring cells via plasma membrane contacts

  2025cites this paper
• Targeted delivery of antioxidants to the myocardium using nanoscale carriers: a modern approach to reducing ischemic-reperfusion injury

  2025cites this paper
• Iron and ferroptosis in kidney disease: molecular and metabolic mechanisms

  2025cites this paper
• Research Progress of Amino Acids Inhibiting Ferroptosis to Improve Myocardial Ischemia-Reperfusion Injury

  2025cites this paper
• Hypoferremia reduces long-term risk of major adverse cardiovascular events after STEMI by averting the myocardial reactive iron storm

  2025cites this paper
• Ironing out the role of ferroptosis in immunity.

  2024cites this paper
• Iron deficiency and supplementation in heart failure

  2024cites this paper
• Myocardial Ischemia/Reperfusion Injury: Mechanism and Targeted Treatment for Ferroptosis

  2024cites this paper
• An emerging double-edged sword role of ferroptosis in cardiovascular disease (Review)

  2024cites this paper
• NDRG1 regulates iron metabolism and inhibits pathological cardiac hypertrophy.

  2024cites this paper
• Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives

  2024cites this paper
• Unlocking the potential of deferoxamine: a systematic review on its efficacy and safety in alleviating myocardial ischemia-reperfusion injury in adult patients following cardiopulmonary bypass compared to standard care

  2024cites this paper
• Insight into myocardial ischemia-reperfusion injury from the perspective of ferroptosis

  2024cites this paper
• Role of ferroptosis in the pathogenesis of heart disease

  2024cites this paper
• Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction Therapy

  2024cites this paper
• Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets

  2023cites this paper
• Regulated cell death in myocardial ischemia-reperfusion injury.

  2023cites this paper
• Research Progress on Ferritin Levels and Cardiovascular Disease

  2023cites this paper
• Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy

  2023cites this paper
• Ferroptosis Involved in Cardiovascular Diseases: Mechanism Exploration of Ferroptosis' Role in Common Pathological Changes.

  2023cites this paper
• Role of dysregulated ferroptosis‑related genes in cardiomyocyte ischemia‑reperfusion injury: Experimental verification and bioinformatics analysis

  2023cites this paper
• Effect and mechanism of circHMGA2 on ferroptosis and pyroptosis in myocardial ischemia-reperfusion model CircHMGA2 exacerbates MI/R injury

  2023cites this paper
• Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment.

  2023cites this paper
• Ferroptosis and Traditional Chinese Medicine for Type 2 Diabetes Mellitus

  2023cites this paper
• Broadening horizons: The role of ferroptosis in myocardial ischemia–reperfusion injury

  2023cites this paper
• Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases

  2022cites this paper
• Combined administration of membrane-permeable and impermeable iron-chelating drugs attenuates ischemia/reperfusion-induced hepatic injury.

  2022cites this paper
• Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms

  2022cites this paper
• Iron metabolism and cardiovascular disease: Basic to translational purviews and therapeutical approach.

  2022cites this paper
• Targeting ferroptosis: a novel insight against myocardial infarction and ischemia–reperfusion injuries

  2022influential citation
• Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation

  2021cites this paper
• Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

  2021cites this paper
• Iron therapy on quality of life in acute heart failure: alternative approaches.

  2021cites this paper
• The molecular mechanisms of ferroptosis and its role in cardiovascular disease.

  2021cites this paper
• A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis

  2021cites this paper
• Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury

  2021cites this paper
• Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury

  2021cites this paper
• Safety and efficacy of iron supplementation after myocardial infarction in mice with moderate blood loss anaemia

  2021cites this paper
• Combination of ponatinib with deferoxamine synergistically mitigates ischemic heart injury via simultaneous prevention of necroptosis and ferroptosis.

  2021cites this paper
• Keeping heart homeostasis in check through the balance of iron metabolism

  2020cites this paper
• Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation?

  2020cites this paper
• Effectiveness of deferiprone-loaded nanocarrier in experimentally induced rhabdomyolysis: A dose-comparison study.

  2020cites this paper
• Iron and Heart Failure

  2020cites this paper
• The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection

  2020cites this paper
• Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention.

  2019cites this paper
• Therapeutic Opportunities for Hepcidin in Acute Care Medicine.

  2019cites this paper
• Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities

  2018cites this paper
• Pathological Roles of Iron in Cardiovascular Disease.

  2018cites this paper
• Lipid peroxidation in cardiac surgery: towards consensus on biomonitoring, diagnostic tools and therapeutic implementation

  2018cites this paper
• Atrial fibrillation in β‐thalassemia patients with a focus on the role of iron‐overload and oxidative stress: A review

  2018cites this paper
• Association of Catalytic (Labile) Iron with Cardiovascular Morbidity and Mortality

  2017cites this paper
• Antihypertrophic Effects of Small Molecules that Maintain Mitochondrial ATP Levels Under Hypoxia

  2017cites this paper
• Novel Antioxidant Therapy Against Myocardial Ischemia– Reperfusion Injury During Percutaneous Coronary Angioplasty

  2016cites this paper
• Reduction in mitochondrial iron alleviates cardiac damage during injury

  2016cites this paper
• Catalytic iron and acute kidney injury.

  2016cites this paper
• Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery.

  2015cites this paper
• Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury

  2015cites this paper
• ACUTE KIDNEY INJURY AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS AND HEART TRANSPLANTATION

  2014cites this paper
• Epidemiological associations between iron and cardiovascular disease and diabetes

  2014cites this paper
• Iron and Intracerebral Hemorrhage: From Mechanism to Translation

  2014cites this paper
• Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes

  2013cites this paper
• The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

  2013cites this paper
• Catalytic (Labile) Iron in Kidney Disease

  2013cites this paper
• Chapter 89 – Catalytic (Labile) Iron in Kidney Disease

  2013cites this paper
• Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study.

  2013cites this paper
• Role of Iron in Hyperoxia-Induced Lung Injury: One Step Forward in Iron Chelation

  2013cites this paper
• TheStatin-IronNexus:Anti-InflammatoryIntervention forArterialDiseasePrevention

  2013cites this paper
• Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs.

  2012cites this paper
• hemorheology in patients undergoing coronary artery bypass grafting

  2012cites this paper
• Cardioprotective activity of chalcones in ischemia/reperfusion-induced myocardial infarction in albino rats.

  2012cites this paper
• Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches.

  2012cites this paper
• Calcium dobesilate may improve hemorheology in patients undergoing coronary artery bypass grafting.

  2012cites this paper
• Oxidative stress and inflammatory response increase during coronary artery bypass grafting with extracorporeal circulation

  2012cites this paper
• Oxidative stress and inflammatory response increase during coronary artery bypass grafting with extracorporeal circulation.

  2012cites this paper
• The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion.

  2012cites this paper
• Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation–Myocardial Infarction

  2012cites this paper
• The dilemma of hyperoxia following positive pressure mechanical ventilation: role of iron and the benefit of iron chelation with deferasirox.

  2011cites this paper
• Peripheral Vascular Disease Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease

  2011cites this paper
• The role of catalytic iron in acute kidney injury.

  2011cites this paper
• Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease.

  2011cites this paper
• The Future of Brain Protection in Cardiac Surgery

  2011cites this paper
• Pig heart preservation with antegrade intracellular crystalloid versus antegrade/retrograde miniplegia.

  2011cites this paper
• Protective effects of deferoxamine mesylate preconditioning on pancreatic tissue in orthotopic liver autotransplantation in rats.

  2011cites this paper
• Brain protection in cardiac surgery

  2011cites this paper
• Reactive oxygen species in cardiovascular disease.

  2011cites this paper
• Oxygen Radical Scavengers

  2011cites this paper
• Cardiac surgery-associated acute renal injury: new paradigms and innovative therapies.

  2010cites this paper
• Remission of paroxysmal atrial fibrillation with iron reduction in haemophilia A

  2010cites this paper
• Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes.

  2009cites this paper
• Loss of heart phospholipid arachidonic acid without phospholipid peroxidation in anaesthetized rats rewarmed after prolonged deep hypothermia.

  2009cites this paper
• Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin‐induced type I diabetic rats

  2009cites this paper